ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2695

Benefits of the Chronic Disease Self-Management Program in Low-Income African American Women with Systemic Lupus Erythematosus:  Results of a Pilot Test

Cristina Drenkard1, Charmayne M. Dunlop-Thomas2, Kirk Easley3, Gaobin Bao4, S. Sam Lim5 and Teresa J. Brady6, 1Medicine, Div Rheumatology, Emory University, Atlanta, GA, 2Medicine Rheumatology, Emory University, Atlanta, GA, 3Emory University, Atlanta, GA, 4Medicine, Emory University, Atlanta, GA, 5Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 6Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: African-Americans, self-management and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Minorities with systemic lupus erythematosus (SLE) are at high risk of poor disease outcomes and may face challenges in effectively self-managing multiple health problems. The Chronic Disease Self-Management Program (CDSMP) is an evidence-based intervention that improves the health of people with chronic illnesses. We aimed to pilot test the benefits of the Chronic Disease Self-Management Program (CDSMP) for low-income African American women with systemic lupus erythematosus (SLE).

Methods: Four CDSMP 6-week workshops were delivered to 49 low-income African American women with SLE who received medical care for ≥6 months at a public lupus clinic in Atlanta, Georgia.  We compared post- minus pre- CDSMP changes (from baseline to 4 months after the start of the intervention) in three general outcomes (health status, self-efficacy and self-management behaviors) using self-reported measures. Additionally, a fourth general outcome (outpatient and inpatient health care utilization) was assessed using electronic administrative records in the 6-month periods before and after the intervention. Paired t-tests or Wilcoxon signed-rank tests were used to compare the post-pre CDSMP change for each outcome measure.

Results: Significant improvements were observed in one of the three measures of health status (physical component summary of the SF-36), in the measure of self-efficacy, and three of the five measures of self-management behaviors outcome (cognitive symptom management, communication with physicians, and medication taking measure).

 

Conclusion: The CDSMP is a promising intervention for low-income African Americans with SLE. It is an inexpensive program with growing availability around the world that should be further evaluated as a resource to improve patient-centered outcomes and decrease health service utilization among SLE patients.

 


Disclosure:

C. Drenkard,
None;

C. M. Dunlop-Thomas,
None;

K. Easley,
None;

G. Bao,
None;

S. S. Lim,
None;

T. J. Brady,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/benefits-of-the-chronic-disease-self-management-program-in-low-income-african-american-women-with-systemic-lupus-erythematosus-results-of-a-pilot-test/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology